financetom
Business
financetom
/
Business
/
Intapp Insider Sold Shares Worth $550,196, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intapp Insider Sold Shares Worth $550,196, According to a Recent SEC Filing
May 28, 2025 1:48 PM

04:19 PM EDT, 05/28/2025 (MT Newswires) -- David H Morton Jr, Chief Financial Officer, on May 23, 2025, sold 10,000 shares in Intapp ( INTA ) for $550,196. Following the Form 4 filing with the SEC, Morton has control over a total of 32,739 common shares of the company, with 32,739 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1565687/000156568725000014/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vanda rejects Future Pak and Cycle Pharma's takeover offers
Vanda rejects Future Pak and Cycle Pharma's takeover offers
Jun 19, 2024
June 19 (Reuters) - Vanda Pharmaceuticals ( VNDA ) said on Wednesday that it has rejected takeover offers UK-based Cycle Pharmaceutical and a revised bid from contract manufacturer Future Pak, adding that both offers undervalue the U.S. drugmaker. ...
Hong Kong's FWD to raise $600 mln in 7-yr subordinated dollar bond, term sheet shows
Hong Kong's FWD to raise $600 mln in 7-yr subordinated dollar bond, term sheet shows
Jun 19, 2024
SYDNEY, June 20 (Reuters) - Hong Kong-based insurer FWD Group is raising $600 million from the sale of a 7-year subordinated dollar bond, according to a term sheet seen by Reuters on Thursday. The initial price guidance given to investors is Treasuries plus 380 basis points, the term sheet said. FWD said in an exchange filing the proceeds would be...
BRIEF-Vanda Pharmaceuticals Says Board Has Rejected Proposals; Recent Unsolicited Takeover Proposals Are Not In The Best Interests Of The Company And Its Shareholders
BRIEF-Vanda Pharmaceuticals Says Board Has Rejected Proposals; Recent Unsolicited Takeover Proposals Are Not In The Best Interests Of The Company And Its Shareholders
Jun 19, 2024
June 19 (Reuters) - Vanda Pharmaceuticals Inc ( VNDA ): * VANDA PHARMACEUTICALS BOARD OF DIRECTORS DETERMINES THAT RECENT UNSOLICITED TAKEOVER PROPOSALS ARE NOT IN THE BEST INTERESTS OF THE COMPANY AND ITS SHAREHOLDERS * BOARD HAS REJECTED PROPOSALS * PROPOSAL FROM CYCLE GROUP AND REVISED PROPOSAL FROM FUTURE PAK UNDERVALUE VANDA Source text for Eikon: Further company coverage: ...
How to buy a second home
How to buy a second home
Jun 19, 2024
Key takeaways Before you buy a second home, get clear on how you want to use the property. Will it be a vacation home for your family or an investment property? Buying a second home is similar to buying a first home, but it can be helpful to find a real estate agent with experience in your desired location....
Copyright 2023-2026 - www.financetom.com All Rights Reserved